Philip Morris (TABAK) H1 2026 earnings summary

Executive summary

• Revenues net of excise tax and VAT were CZK 10.7 billion, broadly stable year-over-year, with a 1.2% increase on a constant currency basis driven by favorable pricing and smoke-free product growth.

• Net income declined by 7.2% to CZK 1.5 billion, mainly due to lower combustible volumes and negative currency impacts.

• Major operational milestone: commercial production of ZYN nicotine pouches began at Kutná Hora in May 2026, strengthening the site’s role in the European market.

• The company continued to expand its smoke-free portfolio and launched several new products and variants in both Czechia and Slovakia.

Financial highlights

• Revenues: CZK 10,740 million (up 0.4% year-over-year; up 1.2% constant currency).

• Profit from operations: CZK 1,755 million (down 7.4% year-over-year).

• Net income: CZK 1,488 million (down 7.2% year-over-year).

• Earnings per share: CZK 542 (down from CZK 584 year-over-year).

• Dividend approved: CZK 1,100 per share (total CZK 3,020 million).

Outlook and guidance

• The company maintains a cautious outlook for 2026 due to external risks, including energy price volatility and geopolitical tensions.

• Continued focus on expanding smoke-free products and managing cost base to maximize investment returns.